Clinical Trials

The following are trials currently active:

For more information please contact Dr. Rogerio I. Neves M.D., Ph.D. (Contact details)


PI Name

Protocol No.


Drabick, Joseph


A Phase II Trial of Dasatinib in KIT-Positive Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melanomas (E2607)

Neves, Rogerio


Multicenter Selective Lymphadenectomy Trial II (MSLT-II): A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecular or Histopathological Evidence of Metastases in the Sentinel Node, coordinated by the John Wayne Cancer Institute

Neves, Rogerio


Histological Features of Sentinel Lymph Node Biopsy for Malignant Melanoma as a Predictive Indicator for Completion Lymphadenectomy

Drabick, Joseph


Phase II Trial of High Dose Interleukin-2 followed by intermittent low dose Temozolomide in patients with Metastatic Malignant Melanoma

Neves, Rogerio


Whole Brain Radiotherapy following Local Treatment of Intracranial Metastases of Melanoma - A Randomized Phase III Trial (ANZMTG)

Drabick, Joseph


A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-risk Melanoma